United States Immuno Oncology Assays Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Immuno-Oncology Assays Market Size reached US$ 6.11 Billion in 2024 and is expected to reach US$ 17.96 Billion by 2033, growing at a CAGR of 12.8% during the forecast period 2025-2033.

Key Development:

United States: Recent Industry Developments

✅ In October 2025, AstraZeneca signed a $555 million milestone-based deal with San Francisco-based Algen Biotechnologies to develop immunology therapies using artificial intelligence (AI) and CRISPR gene-editing technology. Algen retains ownership while AstraZeneca gains exclusive rights to commercialize resulting therapies. The collaboration aims to harness AI not just to analyze data but to create new solutions when paired with CRISPR for immune system disease treatments.

✅ In May 2025, Avammune Therapeutics, a biopharmaceutical startup, raised $12 million in a Series A funding round to advance cancer therapies. The investment was co-led by Capital 2B, Shastra VC, and Kotak Lifesciences Fund I, with additional support from IvyCap Ventures and returning investor 1Crowd. The funding will be used to further develop and advance the company's cancer therapies.

Japan: Recent Industry Developments

✅ In October 2025, Japanese scientists, including Shimon Sakaguchi, were awarded the Nobel Prize in Physiology or Medicine for their work shedding light on how the immune system spares healthy cells. Their research creates openings for possible new autoimmune disease and cancer treatments, marking a significant advancement in immunology.

✅ In October 2025, Japanese scientists reported a new cancer treatment using two bacteria species to eliminate tumors without relying on the immune system. This novel therapy achieved tumor clearance in immunodeficient mouse models, offering a potential alternative for patients with compromised immune systems.

✅ In May 2025, Illumina's TruSightTM Oncology Comprehensive received regulatory approval in Japan for cancer genomic profiling. This approval is expected to expand access to precision oncology options for patients in Japan, enabling clinicians to match available treatments to a patient's genetic tumor profile.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/immuno-oncology-assays-market?sb

Immuno-oncology assays are laboratory tests used to evaluate the immune system's interaction with cancer cells. They help identify biomarkers, assess patient response to immunotherapies, and guide the development and personalization of cancer treatments, enhancing precision oncology outcomes.

Recent Mergers and acquisitions:

United States: Recent M&A Developments

✅ In June 2025, Bristol Myers Squibb entered into an $11.1 billion partnership with BioNTech to co-develop and commercialize BNT327, a PD-L1/VEGF-A bispecific antibody aimed at treating cancer. The deal includes a $1.5 billion upfront payment and up to $7.6 billion in milestone payments. This collaboration positions Bristol Myers Squibb in the competitive race to develop next-generation cancer immunotherapies.

✅ In March 2025, Sun Pharmaceutical Industries announced its acquisition of U.S.-based Checkpoint Therapeutics for $355 million. The acquisition aligns with Sun Pharma's strategy to expand its oncology and immunotherapy portfolio. Checkpoint Therapeutics has developed UNLOXCYT, a treatment for advanced skin cancer approved by the U.S. FDA.

Japan: Recent M&A Developments

✅ In May 2025, Taiho Pharmaceutical of Japan announced the acquisition of Switzerland's Araris Biotech for up to $1.14 billion. Araris focuses on next-generation antibody-drug conjugates to target tumors. This acquisition aims to enhance Taiho Pharmaceutical's capabilities in precision oncology.

Key Players:

=> Merck KGaA, Thermo Fisher Scientific Inc., Lunaphore Technologies SA., Eve Technologies., Vivia Biotech S.L, Illumina, Inc., Charles River Laboratories, Bio-Techne, Creative Biolabs, Miltenyi Biotec, Adipogen Life Sciences, among others.

Growth Forecast Projected:

The Global Immuno-Oncology Assays Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Immuno-Oncology Assays Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=immuno-oncology-assays-market

Key Segments:

➥ By Product Type: Instruments, Consumables, Software & Services
➥ By Assay Type: Cell Proliferation Assays, Cell Migration & Invasion Assays, Phagocytosis Assays, Immune Cell Killing Assays, Others
➥ By Technology: PCR, NGS, Immunoassay, Flow Cytometry, Others
➥ By Indication: Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, Others
➥ By End User: Academic Institutes, Research Organizations, Diagnostic Centers, Others

Regional Analysis for Immuno-Oncology Assays Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Immuno-Oncology Assays producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Immuno-Oncology Assays revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/immuno-oncology-assays-market?sb

FAQ

What is the current size of the Immuno-Oncology Assays Market?

A: In 2024, the Immuno-Oncology Assays Market was valued at US$ 6.11 Billion, reflecting its strong industry presence.

Q2: How large is the Immuno-Oncology Assays Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Immuno-Oncology Assays Market will grow to around US$ 17.96 Billion , demonstrating significant expansion.

Q3: What is the growth rate of the Immuno-Oncology Assays Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 12.8% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.